World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
90
Citations
38094
World Ranking
1059
National Ranking
571

Medicine

D-Index
90
Citations
38094
World Ranking
12043
National Ranking
6175

Glenn Dranoff publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Glenn Dranoff sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 229 publications — 44th percentile

44% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Glenn Dranoff D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Glenn Dranoff sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 90 D-Index — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Glenn Dranoff is affiliated with Harvard Medical School in the United States and focuses on research within the fields of Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology. Their work is predominantly centered on Oncology, Immunology, Molecular Biology, Genetics, and Pulmonary and Respiratory Medicine.

The scientist's research primarily explores topics related to cancer immunotherapy, including Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, CAR-T cell therapy research, Immune cells in cancer, Immune Cell Function and Interaction, Protein Degradation and Inhibitors, and Galectins and Cancer Biology.

Dranoff has co-authored publications notably with Viviana Cremasco, Pushpa Jayaraman, Angelo L. Grauel, David A. Ruddy, and Tyler Laszewski, indicating ongoing collaborations in their research community.

Their recent papers include the following:

  • TGFβ-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts, 2020, Nature Communications
  • A vaccine targeting resistant tumours by dual T cell plus NK cell attack, 2022, Nature
  • Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy, 2023, Cell chemical biology
  • Colon stroma mediates an inflammation-driven fibroblastic response controlling matrix remodeling and healing, 2022, PLoS Biology
  • SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms, 2021, Scientific Reports

The frequent publication venues for Dranoff's work include Cancer Immunology Research, Cell chemical biology, UNC Libraries, Regular and Young Investigator Award Abstracts, and Nature Communications.

Best Publications

  • Combining immunotherapy and targeted therapies in cancer treatment

    Matthew Vanneman;Glenn Dranoff;Glenn Dranoff

  • Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints.

    Shohei Koyama;Esra A. Akbay;Yvonne Y. Li;Grit S. Herter-Sprie

  • Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors

    Esra A. Akbay;Esra A. Akbay;Shohei Koyama;Julian Carretero;Abigail Altabef;Abigail Altabef

  • Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

    F. Stephen Hodi;Martin C. Mihm;Robert J. Soiffer;Frank G. Haluska

  • High-throughput oncogene mutation profiling in human cancer

    Roman K. Thomas;Alissa C. Baker;Ralph M. DeBiasi;Ralph M. DeBiasi;Wendy Winckler;Wendy Winckler

  • Coinhibitory Pathways in Immunotherapy for Cancer.

    Susanne H Baumeister;Gordon J Freeman;Glenn Dranoff;Glenn Dranoff;Arlene H Sharpe

  • Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis

    Kosuke Mima;Reiko Nishihara;Zhi Rong Qian;Yin Cao

  • Prospects for combining targeted and conventional cancer therapy with immunotherapy

    Philip Gotwals;Scott Cameron;Daniela Cipolletta;Viviana Cremasco

  • Immune therapy for cancer.

    Michael Dougan;Glenn Dranoff

  • Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte–macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma

    R Soiffer;T Lynch;M Mihm;K Jung

  • Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients

    F. Stephen Hodi;Marcus Butler;Darryl A. Oble;Michael V. Seiden;Michael V. Seiden

  • TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells.

    Norimoto Kobayashi;Piia Karisola;Victor Peña-Cruz;David M. Dorfman

  • Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma.

    Peter E. Fecci;Duane A. Mitchell;John F. Whitesides;Weihua Xie

  • Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites

    Chris S. Lantz;Jurg Boesiger;Chang Ho Song;Nicolas Mach

  • Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.

    Kosuke Mima;Yasutaka Sukawa;Reiko Nishihara;Zhi Rong Qian

  • STK11/LKB1 deficiency promotes neutrophil recruitment and proinflammatory cytokine production to suppress T cell activity in the lung tumor microenvironment

    Shohei Koyama;Esra A. Akbay;Yvonne Y. Li;Amir R. Aref

  • Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors.

    Pakawat Chongsathidkiet;Christina Jackson;Shohei Koyama;Franziska Loebel

  • T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma

    Karolina Woroniecka;Pakawat Chongsathidkiet;Kristen Rhodin;Hanna Kemeny

  • Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies

    Yannick Bulliard;Rose Jolicoeur;Maurice Windman;Sarah M. Rue

  • Differences in Dendritic Cells Stimulated in Vivo by Tumors Engineered to Secrete Granulocyte-Macrophage Colony-stimulating Factor or Flt3-Ligand

    N Mach;S Gillessen;S B Wilson;C Sheehan

  • Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review†

    Katsuhiko Nosho;Yoshifumi Baba;Noriko Tanaka;Kaori Shima

Frequent Co-Authors

F. Stephen Hodi
F. Stephen Hodi Harvard University
Gordon J. Freeman
Gordon J. Freeman Harvard University
Jerome Ritz
Jerome Ritz Harvard University
Robert J. Soiffer
Robert J. Soiffer Harvard University
Martin C. Mihm
Martin C. Mihm Brigham and Women's Hospital
Kwok-Kin Wong
Kwok-Kin Wong New York University
Richard C. Mulligan
Richard C. Mulligan Harvard University
Edwin P. Alyea
Edwin P. Alyea Harvard University
Scott J. Rodig
Scott J. Rodig Harvard University
Donna Neuberg
Donna Neuberg Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. One popular path is becoming a Nurse Practitioner, with programs varying widely in difficulty. If you’re seeking flexible options, consider reviewing which nurse practitioner program is easiest to find the right fit for your schedule and learning style.

Mental health specialties, such as Psychiatric-Mental Health Nurse Practitioner (PMHNP), offer rewarding careers with growing demand. When selecting a program, it's important to consider clinical experience, so looking at the best pmhnp programs with high clinical placement rates can ensure hands-on learning crucial for this field.

Cost is another key factor for many students. If affordability is a priority, exploring the cheapest online pmhnp certificate programs can help you pursue your goals without excessive financial burden.

After completing advanced degrees like a Doctor of Nursing Practice (DNP), salaries vary significantly by location. To maximize your earning potential, it's useful to review the average dnp salary by state before committing to a program or region.

By understanding these pathways and evaluating program options, you can strategically plan a career that complements your interests in Immunology and healthcare.

Best Scientists Citing Glenn Dranoff

Trending Scientists

Recently Published Articles